Suppr超能文献

一系列选择性 G 蛋白抑制剂的全合成及构效关系研究。

Total synthesis and structure-activity relationship studies of a series of selective G protein inhibitors.

机构信息

Department of Drug Design and Pharmacology, University of Copenhagen, DK-2100 Copenhagen, Denmark.

Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.

出版信息

Nat Chem. 2016 Nov;8(11):1035-1041. doi: 10.1038/nchem.2577. Epub 2016 Jul 25.

Abstract

G proteins are key mediators of G protein-coupled receptor signalling, which facilitates a plethora of important physiological processes. The cyclic depsipeptides YM-254890 and FR900359 are the only known specific inhibitors of the G subfamily of G proteins; however, no synthetic route has been reported previously for these complex natural products and they are not easily isolated from natural sources. Here we report the first total synthesis of YM-254890 and FR900359, as well as of two known analogues, YM-385780 and YM-385781. The versatility of the synthetic approach also enabled the design and synthesis of ten analogues, which provided the first structure-activity relationship study for this class of compounds. Pharmacological characterization of all the compounds at G-, G- and G-mediated signalling provided succinct information on the structural requirements for inhibition, and demonstrated that both YM-254890 and FR900359 are highly potent inhibitors of G signalling, with FR900359 being the most potent. These natural products and their analogues represent unique tools for explorative studies of G protein inhibition.

摘要

G 蛋白是 G 蛋白偶联受体信号转导的关键介质,它促进了许多重要的生理过程。环二肽 YM-254890 和 FR900359 是已知的 G 蛋白亚家族的特异性抑制剂;然而,以前没有报道过这些复杂天然产物的合成路线,而且它们也不容易从天然来源中分离出来。在这里,我们首次报道了 YM-254890 和 FR900359 的全合成,以及两种已知类似物 YM-385780 和 YM-385781 的全合成。该合成方法的多功能性还使设计和合成了十种类似物成为可能,这为该类化合物进行了首次的构效关系研究。所有化合物在 G-、G-和 G-介导的信号转导中的药理学特性提供了抑制的结构要求的简洁信息,并证明 YM-254890 和 FR900359 都是 G 信号转导的高效抑制剂,FR900359 的抑制活性最强。这些天然产物及其类似物代表了探索性研究 G 蛋白抑制的独特工具。

相似文献

10
Recent achievements in developing selective G inhibitors.开发选择性G抑制剂的最新成果。
Med Res Rev. 2020 Jan;40(1):135-157. doi: 10.1002/med.21598. Epub 2019 Jun 19.

引用本文的文献

3
Stabilization of interdomain closure by a G protein inhibitor.通过 G 蛋白抑制剂稳定结构域关闭。
Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2311711121. doi: 10.1073/pnas.2311711121. Epub 2024 Aug 28.
5
A Building Block Approach for the Total Synthesis of YM-385781.一种用于全合成YM-385781的模块法。
European J Org Chem. 2023 May 22;26(20). doi: 10.1002/ejoc.202300365. Epub 2023 Apr 25.
7
Bicyclic Peptide Library Screening for the Identification of Gαi Protein Modulators.双环肽文库筛选鉴定 Gαi 蛋白调节剂。
J Med Chem. 2023 Sep 14;66(17):12396-12406. doi: 10.1021/acs.jmedchem.3c00873. Epub 2023 Aug 16.

本文引用的文献

5
Characterization of UBO-QIC as a Gαq inhibitor in platelets.血小板中UBO-QIC作为Gαq抑制剂的特性研究。
Platelets. 2015;26(8):771-8. doi: 10.3109/09537104.2014.998993. Epub 2015 Mar 3.
7
Recent developments in biased agonism.最近在偏向激动剂方面的进展。
Curr Opin Cell Biol. 2014 Apr;27:18-24. doi: 10.1016/j.ceb.2013.10.008. Epub 2013 Nov 20.
8
Biasing GPCR signaling from inside.从内部调控G蛋白偶联受体信号传导
Sci Signal. 2014 Jan 28;7(310):pe3. doi: 10.1126/scisignal.2005021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验